August 31, 2021
Authored and Edited by Forrest A. Jones; Christina Ji-Hye Yang; Elizabeth D. Ferrill
In Universal Secure Registry LLC v. Apple Inc., No. 2020-2044 (Fed. Cir. Aug. 26, 2021), the Federal Circuit affirmed the district court’s determination that four patents related to securing credit card transactions without a credit card magnetic strip are patent ineligible under 35 U.S.C. § 101.
At the lower court, Apple moved to dismiss USR’s complaint, arguing all four patents claimed patent-ineligible subject matter. The magistrate judge initially found they are not, finding that “a more secure authentication system” is an improvement to computer functionality. However, the district court disagreed, finding that “the secure verification of a person’s identity” is an abstract idea and the remaining claim elements are not transformative.
The Federal Circuit agreed with the district court. Addressing each patent individually, at Alice Step One, the Federal Circuit determined each patent is directed to authentication, which is an abstract idea using “conventional tools” to perform “generic steps and results.” At Alice Step Two, the Court found the claim elements are not transformative because the specifications describe the individual elements as conventional, and there is no plausible indication that the combination of conventional techniques “achieves more than the expected sum of the security provided by each technique.”
United States Court of Appeals for the Federal Circuit (CAFC), patent ineligibility, patentable subject matter, subject matter eligibility, 35 U.S.C. § 101
Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.